Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

被引:147
作者
McCluggage, W. Glenn [1 ]
Judge, Meagan J. [2 ]
Clarke, Blaise A. [3 ]
Davidson, Ben [4 ,5 ]
Gilks, C. Blake [6 ]
Hollema, Harry [7 ]
Ledermann, Jonathan A. [8 ]
Matias-Guiu, Xavier [9 ,10 ]
Mikami, Yoshiki [11 ]
Stewart, Colin J. R. [12 ,13 ]
Vang, Russell [14 ]
Hirschowitz, Lynn [15 ]
机构
[1] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland
[2] Royal Coll Pathologists Australasia, Sydney, NSW, Australia
[3] Univ Toronto, Dept Pathol & Lab Med, Univ Hlth Network, Toronto, ON, Canada
[4] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[5] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway
[6] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands
[8] UCL Canc Inst, Dept Oncol, London, England
[9] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Dept Pathol, Lleida, Spain
[10] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Mol Genet & Res Lab, Lleida, Spain
[11] Kumamoto Univ Hosp, Dept Diagnost Pathol, Kumamoto, Japan
[12] King Edward Mem Hosp, Dept Histopathol, Perth, WA, Australia
[13] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia
[14] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Gynecol Pathol, Baltimore, MD USA
[15] Birmingham Womens Hosp, Dept Cellular Pathol, Birmingham, W Midlands, England
关键词
D O I
10.1038/modpathol.2015.77
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the 'required' and 'recommended' elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.
引用
收藏
页码:1101 / 1122
页数:22
相关论文
共 164 条
[1]  
Kench J., Delahunt B., Griffiths D.F., Et al., Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: Recommendations from the International Collaboration on Cancer Reporting, Histopathology, 62, pp. 203-218, (2013)
[2]  
McCluggage W.G., Colgan T., Duggan M., Et al., Data Set for Reporting of Endometrial Carcinomas: Recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia, Int J Gynecol Pathol, 32, pp. 45-65, (2012)
[3]  
Scolyer R.A., Judge M.J., Evans A., Et al., Data set for pathology reporting of cutaneous invasive melanoma recommendations from the International Collaboration on Cancer Reporting (ICCR), Am J Surg Pathol, 37, pp. 1797-1814, (2013)
[4]  
Jones K.D., Churg A., Henderson D.W., Et al., Data set for reporting of lung carcinomas: Recommendations from International Collaboration on Cancer Reporting, Arch Pathol Lab Med, 137, pp. 1054-1062, (2013)
[5]  
Prat J., FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum, Int J Gynaecol Obstet, 124, pp. 1-5, (2014)
[6]  
Merlin T., Weston A., Tooher R., Extending an evidence hierarchy to include topics other than treatment: Revising the Australian 'levels of evidence, BMC Med Res Methodol, 9, (2009)
[7]  
Suh D.H., Kim J.W., Kim K., Et al., Major clinical research advances in gynecologic cancer in 2012, J Gynecol Oncol, 24, pp. 66-82, (2013)
[8]  
Kim H.S., Ahn J.H., Chung H.H., Et al., Impact of intraopera-tive rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: A meta-analysis, Eur J Surg Oncol, 39, pp. 279-289, (2013)
[9]  
Vergote I., De Brabanter J., Fyles A., Et al., Prognostic importance of degree of differentiation and cyst rupture in stage i invasive epithelial ovarian carcinoma, Lancet, 357, pp. 176-182, (2001)
[10]  
Bakkum-Gamez J.N., Richardson D.L., Seamon L.G., Et al., Influence of intraoperative capsule rupture on outcomes in stage i epithelial ovarian cancer, Obstet Gynecol, 113, pp. 11-17, (2009)